NY: Univ. of Rochester H7N9 vaccine study seeking participants

[Shiloh]

Source: http://www.rochesterhomepage.net/st...bird-flu-study/d/story/1U3whcaL9EaFVhOS1rjffg


U of R Leading In Bird Flu Study
Caroline Tucker
10/14/2013 03:29 PM

...While for many the government shutdown has delayed or stopped many medical trial, this one is the exception. The FDA and the National Institutes of Health want this vaccine study done as soon as possible...It is a live vaccine so participants will have to stay in isolation for about 12 days. It is experimental and there could be side effects, but often those are rare. The goal is to be prepared if it ever starts to spread in the U.S...

...URMC is still looking for participants...People will be compensated anywhere from...

 

[Shiloh]

Re: NY: Univ. of Rochester H7N9 vaccine study seeking participants

Source: http://www.urmc.rochester.edu/news/story/index.cfm?id=3953


URMC Enrolling Subjects to Test H7N9 Pandemic Bird Flu Vaccines
October 14, 2013

URMC researchers are recruiting 48 participants for an isolation-style study testing live-virus bird flu vaccines later this fall.

The project will test two different schedules of nasal vaccine and boosters, hoping to shed light on which approach does a better job priming the immune system against H7N9, a new strain of bird flu identified in China in April this year.

?In a pandemic, time is of the essence,? said study investigator John Treanor, M.D., an internationally known flu expert who heads the University?s Vaccine Research Unit. ?While no cases of H7N9 have yet been identified in the U.S., the Centers for Disease Control is following the situation closely and taking precautionary action, developing and testing a candidate vaccine in case it was ever needed.?

For the study, participants will be assigned to one of two groups. The first will receive intranasal vaccine (containing a live, weakened version of the H7N9 virus) and spend 12 days in a local isolation facility. Several weeks later, they would receive a booster shot of inactivated H7N9 in an outpatient setting.

The second group would follow a similar schedule, but would receive an additional dose of intranasal vaccine?requiring an additional 12-day isolation stay?just 28 days after the initial dose. Then, several weeks later, they also would receive a booster of live, inactivated H7N9 in an outpatient clinic...